United Therapeutics Corporation (UTHR)

United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,114	15,752	10,333	12,674	9,731	6,746
Market Cap Growth	-8.29%	52.44%	-18.47%	30.24%	44.26%	74.53%
Enterprise Value	13,148	11,546	6,197	9,415	7,022	4,738
Last Close Price	400.52	352.84	219.89	278.09	216.08	151.79
PE Ratio	15.63	13.18	10.49	17.43	20.45	13.10
Forward PE	14.30	12.17	9.93	13.57	13.45	11.39
PS Ratio	5.84	5.48	4.44	6.55	5.77	4.55
PB Ratio	2.52	2.44	1.73	2.64	2.46	1.99
P/TBV Ratio	2.56	2.49	1.76	2.67	2.49	2.08
P/FCF Ratio	16.91	14.58	13.82	19.10	20.38	9.69
P/OCF Ratio	13.21	11.87	10.57	15.79	16.27	8.93
PEG Ratio	-	1.02	13.47	1.03	0.72	1.27
EV/Sales Ratio	4.27	4.01	2.66	4.86	4.17	3.19
EV/EBITDA Ratio	8.23	7.60	5.00	9.05	9.53	7.33
EV/EBIT Ratio	8.66	7.98	5.23	9.52	10.22	7.94
EV/FCF Ratio	12.28	10.69	8.29	14.19	14.71	6.80
Debt / Equity Ratio	-	0.05	0.12	0.17	0.20	0.24
Debt / EBITDA Ratio	-	0.22	0.56	0.77	1.09	1.24
Debt / FCF Ratio	-	0.31	0.94	1.21	1.68	1.15
Asset Turnover	0.42	0.40	0.35	0.35	0.35	0.35
Inventory Turnover	2.22	2.30	2.41	1.55	1.36	1.20
Quick Ratio	6.50	4.81	4.10	9.12	6.97	6.16
Current Ratio	7.26	5.25	4.41	9.85	7.61	6.70
Return on Equity (ROE)	19.30%	19.23%	18.27%	16.61%	12.94%	16.67%
Return on Assets (ROA)	12.96%	12.44%	11.22%	11.03%	8.78%	8.74%
Return on Capital (ROIC)	14.19%	13.42%	12.07%	11.94%	9.59%	9.53%
Return on Capital Employed (ROCE)	20.60%	21.80%	18.60%	17.30%	14.10%	13.90%
Earnings Yield	6.86%	7.59%	9.53%	5.74%	4.89%	7.63%
FCF Yield	5.91%	6.86%	7.23%	5.24%	4.91%	10.32%
Buyback Yield / Dilution	1.52%	2.41%	-2.47%	-2.54%	-6.05%	-1.83%

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q